SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GSII - GENERAL SURGICAL INNOVATIONS, INC.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Elroy who wrote (80)10/16/1997 11:12:00 AM
From: Lighthouse   of 211
 
A very good question for the conference call. I have not seen or heard of any names mentioned, but the company is so close to the conference call that I doubt they will say anything until then. Will post any developments after the call.

GSI is planning on using its small direct salesforce in Vascular applications to sell direct in high-use markets. I suspect that distributors will get the second tier markets and some follow on efforts in the bigger markets. Unless the direct force takes off like a cannon shot I suspect that revenues will have to ramp over several qtrs. ($250,000 - $500,000 in the December qtr for this product would be a very strong showing IMO, but this may be overly aggressive)

Your take?

Regards,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext